Stock DUL ALNYLAM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Alnylam Pharmaceuticals, Inc. Börse Stuttgart

Equities

DUL

US02043Q1076

Market Closed - Börse Stuttgart
Other stock markets
 15:14:12 28/06/2024 BST 		5-day change 1st Jan Change
227.6 EUR -1.47% Intraday chart for Alnylam Pharmaceuticals, Inc. +55.68% +29.61%
06-28 UBS Adjusts Price Target on Alnylam Pharmaceuticals to $288 From $253, Maintains Buy Rating MT
06-27 Stifel Adjusts Price Target on Alnylam Pharmaceuticals to $295 From $215, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MODERNA, INC. Stock Moderna, Inc.
 45.51B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.52B
LONZA GROUP AG Stock Lonza Group AG
 38.13B
CELLTRION, INC. Stock Celltrion, Inc.
 26.03B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 25.92B
  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. DUL Stock
  5. Charts Alnylam Pharmaceuticals, Inc.
  6. Sector Chart